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Establishing the clinical signiﬁcance of symptoms of sexual dysfunction is challenging. To
address this, the ﬁfth edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) introduced two new morbidity criteria (duration and symptom severity) to the existing
criteria of distress. This study sought to establish the impact of these three criteria on the
population prevalence of sexual function problems. The data come from a national probability
survey (Natsal-3) and are based on 11,509 male and female participants aged 16–74, reporting
at least one sexual partner in the past year. The key outcomes were: proportion of individuals
reporting proxy measures of DSM-5 problems, and the proportion of those meeting morbidity
criteria. We found that among sexually active men, the prevalence of reporting one or more of
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four speciﬁc sexual problems was 38.2%, but 4.2% after applying the three morbidity criteria;
corresponding ﬁgures for women reporting one or more of three speciﬁc sexual problems, were
22.8% and 3.6%. Just over a third of men and women reporting a problem meeting all three
morbidity criteria had sought help in the last year. We conclude that the DSM-5 morbidity
criteria impose a focus on clinically signiﬁcant symptoms.
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Introduction
The challenge of distinguishing mild difﬁculties from clin-
ical dysfunction has troubled psychiatry for many years
(Mitchell & Graham, 2008; Wakeﬁeld, 1992). In the ﬁeld of
sexual dysfunction, this issue has become critical (Balon,
Segraves, & Clayton, 2007), with the development of pharma-
cological treatments prompting concerns about the medicali-
zation of sexual problems (Moynihan, 2010; Tiefer, 2012).
Mild and transient sexual function problems are sufﬁciently
common (Laumann, Paik, & Rosen, 1999; Mitchell et al.,
2013) to be considered normal. The use of morbidity criteria
—such as personal distress—to differentiate transient pro-
blems from dysfunction has generated signiﬁcant debate
(Hendrickx, Gijs, & Enzlin, 2013; Mitchell & Graham,
2008). The application of morbidity criteria in epidemiological
research has been inconsistent, detracting from efforts to accu-
rately assess prevalence, and leading to calls for more systema-
tic measurement of severity (Derogatis & Burnett, 2008).
The Diagnostic and Statistical Manual of Mental Disorders
(DSM American Psychiatric Association [APA], 2013) pro-
vides a standard and internationally recognized system for
classifying sexual dysfunction. In the recently published ﬁfth
edition (DSM-5), two new conditions for morbidity were
added to the existing distress criterion stipulated in DSM-IV-
TR. There is now a requirement, across all diagnoses, that
symptoms have persisted for a minimum duration of approxi-
mately six months; have been experienced in almost all or all
(approximately 75%—100%) sexual encounters or have been
persistent/recurrent; and have caused the individual clinically
signiﬁcant distress. The changes were speciﬁcally designed to
improve precision, “reduce likelihood of overdiagnosis” and
“distinguish transient sexual difﬁculties from more persistent
sexual dysfunction” (APA, 2013, p. 809–816). The diagnostic
categories were also extensively revised (see Box 1), reﬂecting
a move away from the conceptualization of sexual response as
a linear progression, essentially similar for women and men,
towards recognition of substantial inter-personal variation
without a single underlying model (Carvalheira, Brotto, &
Leal, 2010; Graham, 2015; Sand & Fisher, 2007). Where the
previous version (DSM-IV-TR) referred to “psychophysiolo-
gical changes” and the “sexual response cycle” (APA, 2000; p.
261), in DSM-5 sexual dysfunction is deﬁned as “a clinically
signiﬁcant disturbance in a person’s ability to respond sexually
or to experience sexual pleasure” (American Psychiatric
Association, 2013, p. 423). Furthermore, DSM-IV TR
included subtypes “due to psychological factors” and “due to
combined factors” (both psychological factors and general
medical condition are etiological factors), but DSM-5 now
stipulates a wider range of “associated features” to be consid-
ered during assessment and treatment. These are: “1) partner
factors; 2) relationship factors; 3) individual vulnerability fac-
tors, psychiatric comorbidity or stressors; 4) cultural or reli-
gious factors; and 5) medical factors relevant to prognosis,
course, or treatment” (APA, 2013, p. 423).
The changes to morbidity criteria have met with consider-
able opposition (Balon & Clayton, 2014; Clayton, DeRogatis,
Rosen, & Pyke, 2012; Sungur & Gündüz, 2014). The chief
criticism has been that “raising the bar” (Clayton et al., 2012,
p. 2040) for a diagnosis will exclude individuals with dys-
function from treatment. The DSM-5 Sexual Dysfunctions
subworkgroup has countered this criticism (Binik, Brotto,
Graham, & Segraves, 2010; Graham, Brotto, & Zucker,
2014), citing the empirical basis for the DSM-5 criteria and
pointing to the fact that previous versions of the DSM were
criticized for poorly operationalized criteria (Binik et al.,
2010). An explicit purpose of introducing morbidity criteria
was to reduce the number of false positives (Sungur &
Gündüz, 2014) and to provide more clinically useful thresh-
olds (Binik et al., 2010). Some critics, however, have argued
that the changes will “create havoc in the entire area of sexual
dysfunction” (Balon & Clayton, 2014, p. 1227). On the other
hand, narrower evidence-based criteria may actually protect
patients by preventing healthy individuals with transient pro-
blems from being labeled as sick (Moynihan, 2010).
However, potential loss of sensitivity with use of these
more stringent criteria has not yet been investigated.
Given this debate, it is important to understand the impact
of these morbidity criteria on the population prevalence of
sexual dysfunction. This is not yet known because, to date,
no study has employed all three morbidity criteria. In Britain’s
third National Survey of Sexual Attitudes and Lifestyles
(Natsal-3) we used different symptom measures but similar
morbidity criteria to the DSM-5, enabling us to show the effect
on prevalence estimates of sexual function problems and
extent of overlap between problems when all three morbidity
criteria are applied.We also used our survey data to investigate
the empirical evidence for another key change in DSM-5: the
introduction of the broader range of associated features rele-
vant to assessment/treatment. Finally, we investigated the pro-
portion of those reporting morbid difﬁculties who had sought
professional help.
MITCHELL ET AL.
956
Method
Participants and Procedure
Natsal-3 is a stratiﬁed probability sample survey of
15,162 men and women aged 16–74 years in Britain, inter-
viewed between September 2010 and August 2012. We
used a multi-stage, clustered, and stratiﬁed probability sam-
ple design and participants were interviewed using a com-
bination of computer-assisted face-to-face and self-interview
(CASI) for the more sensitive questions. The survey instru-
ment underwent thorough cognitive testing and piloting
(Gray & Nicholson, 2009). After weighting to adjust for
unequal probabilities of selection, the Natsal-3 sample was
broadly representative of the British population as described
by 2011 Census ﬁgures (Erens et al., 2013).
The estimated response rate was 57.7%, while the co-
operation rate was estimated at 65.8% (of all eligible
addresses contacted). Details of the survey methodology
are published elsewhere (Erens et al., 2013; Mercer et al.,
2013). Natsal-3 was approved by the NRES Committee
South Central—Oxford A (Ref: 10/H0604/27). Participants
provided oral informed consent for interviews.
Outcome Measures
Participants reporting at least one sexual partner1 in the
past year were classiﬁed as sexually active and asked whether
they had experienced any of a list of eight difﬁculties with
their sex life lasting 3 months or longer in the past year. If
they reported a problem they were then directed to three
further items asking how long they had experienced the
problem (options: at least 3 months but less than 6 months,
at least 6 months but less than a year, at least a year but less
than 5 years, 5 years or longer); how often the symptoms
occurred (options: always, very often, sometimes, not very
often); and how they felt about the problem (options: not at
all distressed, a little distressed, fairly distressed, very dis-
tressed). Several of the problems we assessed, including
painful sex in men, and vaginal dryness in women, do not
have DSM-5 diagnoses and so were excluded from our
analyses. Box 1 summarises the DSM-5 diagnostic criteria
alongside the Natsal-3 survey items and morbidity criteria.
We use the term “morbid sexual function problem” to refer to
a problem meeting all three DSM-5 morbidity criteria. We
assessed the proportion of individuals with one or more
“morbid” problem who had sought professional help. This
included family doctor, sexual health/genito-urinary medi-
cine/STI clinic, psychiatrist or psychologist, relationship
counsellor or other type of clinic or doctor.
We explored associations between reporting one or more
problem(s) meeting all three morbidity criteria and a range
of factors usually considered during a clinical assessment to
support diagnosis and inform treatment. Items from the
survey were selected to be consistent with ﬁve groups of
associated features described in DSM-5 as being potentially
relevant to etiology and/or treatment. These were: partner
factors; relationship factors; individual vulnerability factors,
including psychiatric co-morbidity, history of abuse, and
unemployment; cultural or religious factors; and medical
factors relevant to etiology and treatment (APA, 2013).
Statistical Analysis
All analyses were done using the complex survey func-
tions of STATA (version 12; StataCorp LP, College Station,
Texas) to account for the weighting, clustering, and stratiﬁ-
cation of the data. Analysis was restricted to men and
women reporting at least one sexual partner (of either gen-
der) in the past year. We present descriptive statistics for
reporting of sexual function problems meeting DSM-5 mor-
bidity criteria and tested for associations with age and
gender differences using the Chi square statistic. We used
age-adjusted logistic regressions to examine the associations
between reporting one or more morbid sexual function
problem and the ﬁve groups of factors. We also examined
associations with each morbid sexual function problem
separately to then assess whether associations were broadly
consistent across problems or not.
Results
The demographic characteristics of the total Natsal-3
sample (n = 15,162) are described elsewhere (Mercer
et al., 2013). For this study, we used data from sexually-
active participants (n = 4,840 men and n = 6,669 women)
deﬁned as those who reported one or more sexual partner in
the past year (Table 1).
Table 2 shows the proportion of sexually active men and
women reporting sexual function problems lasting three
months or more in the last year, as well as the proportion
reporting problems meeting DSM-5 morbidity criteria.
Among sexually active men, the one-year population preva-
lence estimates of individual sexual function problems lasting
three months or more ranged from 9.2% (difﬁculty reaching
climax), through 12.9% (getting and keeping an erection) to
15% (lacking interest in sex and reached climax more quickly
than you would like). For all four problems the proportions
fulﬁlling all three morbidity criteria were much lower, with
difﬁculty reaching climax and lacking interest in sex showing
sharper declines than the other problems, to 0.5% and 0.8%
respectively. For example, a third of men reporting lack of
interest had frequent symptoms, but less than 15% reported
being distressed about it; and over 40% of men who had
difﬁculty reaching climax had experienced the problem for
six months or more, but only 16.3% experienced frequent
symptoms. Distress was approximately twice as common in
men reporting trouble getting or keeping an erection than in the
other problems. In all, 11.1% of men reporting one or more
1Deﬁned as one person with whom they had had sex on at least one
occasion, where sex is deﬁned as vaginal intercourse, oral sex or anal sex.
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problemmet all three morbidity criteria: fewer than 6% of men
reporting lack of interest in sex and fewer than 6% of men
reporting difﬁculty reaching climax; 11.6% of men reporting
reaching climax too quickly; and 14.1% of men reporting
erectile difﬁculties. Thus, after applying morbidity criteria,
erectile difﬁculties and reaching climax too quickly became
the most commonly reported problems (1.8% and 1.7% of all
sexually active men, respectively). In total, 4.2% of sexually
active men reported one or more sexual function problem
meeting DSM-5 morbidity criteria in the past year.
Considering morbid sexual function problems, only difﬁculty
getting/keeping an erection was strongly associated with older
Box 1. Criteria for sexual function problems: Comparison of Natsal-3 survey and DSM-5
DSM-5 diagnostic criteria: Verbatim extracts from DSM-5 (American
Psychiatric Association, 2013, pp. 423‒450) Natsal-3 survey item
MORBIDITY CRITERIA
Morbidity criteria for each difﬁculty
Symptoms experienced on almost all or all occasions (approx. 75–100%)*
Symptoms must have been present for at least 6 months
Symptoms cause clinically signiﬁcant distress in the individual
* Note that for Male Hypoactive Sexual Desire Disorder (HSDD) and Genito-
Pelvic Pain/Penetration Disorder, symptoms should be ‘persistent or recurrent’
rather than occurring ‘always or almost always’
Report if difﬁculty experienced for three months or more in last
year. Items on morbidity asked for each difﬁculty endorsed
Morbidity criteria for each difﬁculty:
Symptoms occur ‘very often’ or ‘always’
Experienced for at least 6 months
Participant is ‘fairly distressed’ or ‘very distressed’ about the
difﬁculty
FEMALE PROBLEMS
Female Orgasmic Disorder
Either of the following symptoms:
1. Marked delay in, marked infrequency, or absence of orgasm.
2. Markedly reduced intensity of orgasmic sensation.
Did not reach a climax (experience an orgasm) or took a long time
to reach a climax despite feeling excited or aroused
Female Sexual Interest/Arousal disorder (FSIAD).
Diagnosis requires 3 or more of the following symptoms:
1. Absent/reduced interest in sexual activity.
2. Absent/reduced sexual/erotic thoughts or fantasies.
3. No/reduced initiation of sexual activity, and typically unreceptive to a partner’s
attempts to initiate.
4. Absent/reduced sexual excitement/pleasure during sexual activity on almost all or
all (approximately 75%–100% of) sexual encounters (in identiﬁed situational
contexts or, if generalized, in all contexts).
5. Absent/reduced sexual interest/arousal in response to any internal or external
sexual/erotic cues (e.g., written, verbal, visual).
6. Absent/reduced genital or nongenital sensations during sexual activity on almost
all or all (approximately 75%–100% of) sexual encounters (in identiﬁed situa-
tional contexts or, if generalized, in all contexts).
Reported BOTH of these items:
Lacked interest in having sex
Felt no excitement or arousal during sex
Genito Pelvic Pain/Penetration disorder.
Persistent or recurrent difﬁculty with one or more of the following:
1. Having vaginal intercourse/penetration.
2. Marked vulvovaginal or pelvic pain during vaginal intercourse or penetration
attempts.
3. Marked fear or anxiety either about vulvovaginal or pelvic pain in anticipation
of, during, or as a result of vaginal penetration.
4. Marked tensing or tightening of the pelvic ﬂoor muscles during attempted vaginal
penetration.
Felt physical pain as a result of sex
MALE PROBLEMS
Delayed ejaculation
Either of the following symptoms:
Marked delay in ejaculation
Marked infrequency or absence of ejaculation
Did not reach a climax (experience an orgasm) or took a long time
to reach a climax despite feeling excited or aroused
Erectile Disorder:
At least one of the following:
1. Marked difﬁculty in obtaining an erection during sexual activity.
2. Marked difﬁculty in maintaining an erection until the completion of sexual
activity.
3. Marked decrease in erectile rigidity.
Had trouble getting or keeping an erection
Male Hyposexual Desire Disorder:
Persistently or recurrently deﬁcient (or absent) sexual/erotic thoughts or fantasies
and desire for sexual activity.
Lacked interest in having sex
Premature (Early) Ejaculation:
A persistent or recurrent pattern of ejaculation occurring during partnered sexual
activity within approximately 1 minute following vaginal penetration and before
the individual wishes it.
Reached climax (experienced an orgasm) more quickly than you
would like
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age (Figure 1), increasing from 0.6% of men aged 16–24 to
5.1% of men aged 65–74 (p < 0.0001).
Among sexually active women, the one-year population
prevalence estimates of sexual function problems lasting
three months or more ranged from 6.5% (lack of interest
and arousal) to 16.3% (difﬁculty reaching climax). As with
men, the proportion of women fulﬁlling all three DSM-5
morbidity criteria was much lower for the three problems
included in the analysis. The decline was less among
women reporting pain, of whom 25% met all three
morbidity criteria, compared with 9.1% of women reporting
lack of interest and arousal and 11.6% of women reporting
difﬁculty reaching climax. In particular, the proportion
reporting distress was twice as high among women report-
ing pain compared with the other two problems. In all,
16.0% of women reporting one or more problem met all
three morbidity criteria. After applying morbidity criteria,
difﬁculty reaching climax and pain were the most com-
monly reported sexual problems, each reported by 1.9% of
women, followed by lack of interest and arousal, reported
Table 1. Sexually active population demographics
Men Women
Unweighted, weighted denominators 4840, 5975 6669, 5755
Percent 95% C.I. Percent 95% C.I.
Age group
16–24 15.7% (14.7–16.7) 16.0% (15.2–16.9)
25–34 20.7% (19.5–21.9) 21.6% (20.7–22.6)
35–44 21.7% (20.2–23.3) 22.4% (21.2–23.7)
45–54 19.9% (18.4–21.3) 20.6% (19.3–22.0)
55–64 14.2% (13.0–15.5) 13.1% (12.1–14.2)
65–74 7.8% (7.0–8.7) 6.2% (5.5–6.9)
Marital status
Married or civil partnership 54.7% (53.1–56.3) 55.2% (53.7–56.6)
Cohabitation 14.7% (13.6–15.8) 14.2% (13.2–15.2)
Previously married 6.0% (5.4–6.6) 8.3% (7.6–9.1)
Single and never married 24.6% (23.3–25.9) 22.3% (21.3–23.4)
Ethnic origin
White 88.6% (87.4–89.7) 89.5% (88.5–90.3)
Mixed 1.6% (1.2–2.0) 2.0% (1.7–2.4)
Asian or Asian British 5.6% (4.8–6.5) 4.4% (3.8–5.0)
Black or Black British 3.2% (2.6–4.0) 3.1% (2.6–3.7)
Other 1.0% (0.7–1.5) 1.1% (0.8–1.4)
Self-deﬁned sexual identity
Heterosexual/straight 97.3% (96.7–97.8) 97.1% (96.6–97.5)
Gay/lesbian 1.5% (1.2–2.0) 1.1% (0.9–1.4)
Bisexual 1.1% (0.8–1.5) 1.6% (1.3–1.9)
Other 0.1% (0.0–0.2) 0.2% (0.1–0.4)
National Statistics Socio-Economic Classiﬁcation
Managerial and professional occupations 38.8% (37.1–40.5) 33.7% (32.4–35.1)
Intermediate occupations 17.3% (16.0–18.7) 21.1% (19.9–22.2)
Semiroutine and routine occupations 32.3% (30.7–33.9) 26.9% (25.7–28.1)
Never worked and long-term unemployed 4.4% (3.8–5.1) 10.9% (10.1–11.9)
Full-time students 7.2% (6.5–8.1) 7.4% (6.7–8.1)
Quintile of Index of Multiple Deprivationa
1 [least deprived] 21.4% (19.9–23.0) 21.0% (19.6–22.5)
2 21.2% (19.6–22.8) 21.0% (19.5–22.5)
3 19.6% (18.1–21.1) 19.4% (18.0–20.8)
4 19.8% (18.3–21.4) 19.7% (18.4–21.2)
5 [most deprived] 18.0% (16.6–19.5) 18.9% (17.6–20.2)
aA multidimensional measure of area (neighbourhood)-level deprivation based on the participant’s postcode;
Index of Multiple Deprivation scores for England, Scotland, and Wales were adjusted before assignment to
quintiles by use of a method by Payne and Abel (2012).
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Table 2. Percentage of sexually active men and women reporting sexual function problems for at least three months in the last year and
proportion reporting problems meeting DSM-5 morbidity criteria
Of those reporting the problem
Population %
reporting
problem
Lasting
6 months or
more
Always/very
often
symptomatic
Fairly/very
distressing
Meets all 3
DSM-5
criteria
Population % meeting
DSM-5 morbidity
criteria
Men (Unw 4840; W 5975)
Lacked interest in having sex 15.0% 35.1% 32.2% 14.4% 5.2% 0.8%
95% C.I. (13.9–16.2) (31.0–39.4) (28.3–36.3) (11.8–17.5) (3.6–7.5) (0.5–1.1)
Trouble getting or keeping an erection 12.9% 64.2% 26.7% 40.9% 14.1% 1.8%
95% C.I. (11.8–14.0) (59.6–68.4) (22.8–30.8) (36.5–45.5) (11.3–17.5) (1.4–2.3)
Difﬁculty in reaching climax 9.2% 43.7% 16.3% 17.3% 5.5% 0.5%
95% C.I. (8.3–10.1) (38.6–49.0) (12.9–20.4) (13.6–21.7) (3.5–8.5) (0.3–0.8)
Reached climax more quickly than you would like 14.9% 53.3% 29.9% 22.2% 11.6% 1.7%
95% C.I. (13.7–16.2) (48.9–57.7) (26.2–33.9) (18.8–25.9) (9.0–14.7) (1.3–2.2)
Experienced one or more of these problems 38.2% 53.0% 32.8% 24.9% 11.1% 4.2%
95% C.I. (36.6–39.8) (50.3–55.7) (30.4–35.3) (22.7–27.2) (9.5–12.9) (3.6–5.0)
Women (Unw 6669; W 5755)
Lacked interest and arousal 6.5% 55.8% 33.1% 23.8% 9.1% 0.6%
95% C.I. (5.9–7.2) (50.3–61.1) (27.8–38.8) (19.6–28.6) (6.4–12.8) (0.4–0.9)
Difﬁculty in reaching climax 16.3% 52.9% 39.0% 22.0% 11.6% 1.9%
95% C.I. (15.3–17.3) (49.5–56.3) (35.7–42.5) (19.4–24.8) (9.7–13.8) (1.6–2.3)
Felt physical pain as a result of sex 7.4% 62.1% 50.8% 45.5% 25.0% 1.9%
95% C.I. (6.7–8.3) (57.1–66.8) (45.6–56.1) (40.5–50.5) (20.7–29.8) (1.5–2.3)
Experienced one or more of these problems 22.8% 55.5% 43.6% 28.8% 16.0% 3.6%
95% C.I. (21.7–24.0) (52.5–58.4) (40.6–46.6) (26.3–31.4) (14.0–18.2) (3.2–4.2)
Unw = unweighted denominator; W = Weighted denominator
1.
0%
1%
2%
3%
4%
5%
6%
7%
8%
Lacked interest in
having sex
(p = 0.3631)
Trouble getting or
keeping an
erection
(p < 0.0001)
Difficulty in
reaching climax
(p = 0.1696)
Reached climax
more quickly than
you would like
(p = 0.3357)
Experienced one
or more of these
(p = 0.0008)
Lacked interest
and arousal
(p = 0.4108)
Difficulty in
reaching climax
(p = 0.0189)
Felt physical pain
as a result of sex
(p = 0.0017)
Experienced one
or more of these
(p = 0.0103)
Men Women
Unw W Unw W Unw W Unw W Unw W Unw W
Men 1279 936 1376 1238 719 1298 630 1186 512 849 324 469
Women 1662 923 2236 1246 1050 1290 871 1186 569 755 281 355
 45-54 years  55-64 years  65-74 years 16-24 years  25-34 years  35-44 years
Unw-unweighted
W-weighted
P value for trend
Figure 1. Prevalence of sexual function problems meeting DSM-5 morbidity criteria in the last year by gender and age group, among the sexually active
participants.
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by 0.6% of women. In all, 3.6% of sexually active women
reported one or more problems meeting DSM-5 morbidity
criteria in the past year. We found signiﬁcant variation by
age for difﬁculty reaching climax (p = 0.02) and pain
(p = 0.002, but not for lack of interest and arousal
(Figure 1). There was no linear increase in age for reporting
one or more morbid sexual function problem; rather, pro-
blems were most common in younger age groups (16–34)
and in later mid-life (55–64), declining signiﬁcantly after
age 64.
Overlap Between Severe Sexual Function Problems
Table 3 (a and b) shows the overlap in reported morbid
sexual function problems among sexually active men and
women. Among men who met criteria for morbid lack of
interest in sex, approximately a third (35.9%) also reported
another of the morbid sexual function problems. Although
numbers are small, fewer men reporting erectile difﬁculties
(16.5%) and reaching climax more quickly than they would
like (11.0%) also reported another morbid problem. Among
women reporting morbid lack of interest and arousal, most
(71.6%) also reported another morbid problem; speciﬁcally,
57.8% also reported morbid orgasmic difﬁculty and 33.4%
also experienced morbid pain. By contrast, only a minority
of women reporting difﬁculty reaching climax (26.1%) and
pain (18.8%) also reported another morbid problem.
Factors Relevant to Clinical Assessment
Table 4 shows factors considered relevant to diagnosis and
treatment of sexual disorders in DSM-5, and their association
with reporting one or more morbid sexual function problem.
Among women, there were signiﬁcant associations with all
factors except unemployment, religiosity and the attitude that
‘sex without love is OK’. The strongest associations were with
feeling anxious during sex (OR 12.15; 95% C.I. 8.55–17.25),
reporting vaginal dryness (7.19; 5.23–9.87), and reporting a
health condition that affected sexual activity and enjoyment
(7.44; 5.48–10.09). The sexual relationship was also important,
in particular not sharing the same level of interest in sex (4.43;
3.07–6.39) and not sharing the same likes and dislikes (3.92;
2.54–6.03). When we analyzed associations with each indivi-
dual problem (supplemental Table 1) we found they were
broadly consistent across problems in the sense that there were
no instances of strong associations in opposite directions.
Qualitative assessment of odds ratios showed that lack of inter-
est and arousal was more strongly associated than other indivi-
dual problems with anxiety and with not sharing the same level
of interest in sex as a partner; pain was more strongly associated
with difﬁculty talking about sex; and difﬁculty reaching climax
was more strongly associated with having a partner with sexual
difﬁculties.
Similar to women, there was a strong association amongmen
between reporting one or more morbid sexual function problem
and anxiety (OR 7.46; 95%CI 5.12–10.87) and with all three
health factors (number of self-reported chronic conditions,
health and medication affecting sexual activity and enjoyment
Table 3a Overlap between reported sexual function problems meeting DSM-5 morbidity criteria: Sexually active men
Percentage also experiencing:
Men
Lacked interest
in having sex
Trouble getting
or keeping an
erection
Difﬁculty in
reaching climax
Reached climax
more quickly
than you would
like
Any of the other
problems in table Denominators
% 95% CI % 95% CI % 95% CI % 95% CI % 95% CI Unw W
Lacked interest in having sex - - 12.4% (5.2–26.8) 15.5% (6.3–33.3) 17.4% (7.4–35.7) 35.9% (20.6–54.7) 37, 46
Trouble getting or keeping an erection 5.4% (2.3–11.9) - - 10.8% (5.4–20.3) 3.0% (1.0–8.5) 16.5% (9.9–26.2) 82, 108
Difﬁculty in reaching climax* NA - NA - - - NA - NA - 22, 30
Reached climax more quickly than
you would like
7.9% (3.3–17.4) 3.2% (1.1–8.9) 1.5% (0.2–10.1) - - 11.0% (5.6–20.6) 82, 103
* Numbers too small to permit analysis
Table 3b. Overlap between reported sexual function problems meeting DSM-5 morbidity criteria: Sexually active women
Percentage also experiencing:
Women
Lacked interest and
arousal in having sex
Difﬁculty in
reaching climax
Felt physical pain as
a result of sex
Any of the other
problems in the table Denominators
% 95% CI % 95% CI % 95% CI % 95% CI Unw W
Lacked interest and arousal in having sex - - 57.8% (40.1–73.6) 33.4% (18.6–52.4) 71.6% (54.4–84.2) 42, 34
Difﬁculty in reaching climax 18.1% (11.5–27.5) - - 14.1% (8.6–22.2) 26.1% (18.2–35.9) 145, 109
Felt physical pain as a result of sex 10.7% (5.8–18.7) 14.3% (8.7–22.7) - - 18.8% (12.2–27.8) 119, 107
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Table 4. Associations between sexual function problems meeting DSM-5 morbidity criteria and factors relevant to etiology and
management
Men Women
% 95% C.I. aAOR 95% C.I. p-value Denominatorsa % 95% C.I. aAOR 95% C.I. p-value Denominatorsa
Overall 4.2% (3.6–5.0) - - - 4840, 5975 3.6% (3.2–4.2) - - - 6669, 5755
Age group 0.0002 0.0171
16–24 2.3% (1.6–3.4) 1.00 1279, 936 4.4% (3.5–5.6) 1.00 1662, 923
25–34 3.7% (2.6–5.1) 1.59 (0.95–2.64) 1376, 1238 4.2% (3.3–5.3) 0.94 (0.67–1.33) 2236, 1246
35–44 3.5% (2.5–5.1) 1.52 (0.91–2.55) 719, 1298 2.8% (1.9–4.0) 0.61 (0.39–0.96) 1050, 1290
45–54 4.1% (2.6–6.2) 1.77 (1.00–3.13) 630, 1186 3.1% (2.1–4.6) 0.68 (0.42–1.10) 871, 1186
55–64 6.6% (4.7–9.2) 2.93 (1.74–4.94) 512, 849 5.3% (3.6–7.7) 1.20 (0.74–1.93) 569, 755
65–74 7.6% (5.0–11.6) 3.43 (1.89–6.24) 324, 469 1.3% (0.5–3.3) 0.29 (0.11–0.75) 281, 355
PARTNER AND RELATIONSHIP FACTORS
Partner had sexual
difﬁculties past
year
0.0676 0.0002
No 3.8% (3.0–4.7) 1.00 2431, 3454 3.2% (2.6–3.9) 1.00 3726, 3498
Yes 6.1% (4.1–8.9) 1.59 (0.97–2.61) 513, 763 6.4% (4.6–8.8) 2.26 (1.47–3.48) 649, 719
Always easy to talk
about sex with
partner
0.0001 0.0057
Yes 2.2% (1.5–3.1) 1.00 1695, 1899 2.5% (1.8–3.4) 1.00 1746, 1451
Else 5.2% (4.4–6.2) 2.26 (1.50–3.42) 3123, 4050 4.0% (3.5–4.7) 1.66 (1.16–2.38) 4907, 4289
Partner shares same
interest level in
sex
<0.0001 <0.0001
Yes 3.1% (2.4–4.0) 1.00 2270, 3233 2.0% (1.5–2.6) 1.00 3211, 3064
No 7.7% (5.7–10.3) 2.65 (1.75–4.02) 676, 988 8.3% (6.7–10.3) 4.43 (3.07–6.39) 1166, 1155
Partner shares same
sexual likes and
dislikes
0.0001 <0.0001
Yes 3.7% (2.9–4.6) 1.00 2650, 3803 3.1% (2.6–3.8) 1.00 4079, 3908
No 9.0% (6.0–13.2) 2.65 (1.61–4.35) 296, 418 11.2% (7.9–15.7) 3.92 (2.54–6.03) 297, 310
INDIVIDUAL VULNERABILITY
Felt anxious during
sex
<0.0001 <0.0001
No 3.4% (2.8–4.1) 1.00 4548, 5651 2.5% (2.1–3.0) 1.00 6264, 5453
Yes 19.4% (15.0–24.9) 7.46 (5.12–10.87) 292, 324 23.5% (18.8–28.9) 12.15 (8.55–17.25) 405, 302
Experienced non-
volitional sex,
everb
0.1269 <0.0001
No 4.1% (3.5–4.9) 1.00 4706, 5825 3.1% (2.6–3.6) 1.00 5815, 5055
Yes 7.9% (3.2–18.3) 2.09 (0.81–5.40) 71, 82 8.9% (6.8–11.6) 3.10 (2.21–4.35) 684, 579
Unemployed last
week
0.0198 0.8154
No 3.6% (2.9–4.4) 1.00 3277, 4307 3.7% (3.1–4.4) 1.00 4001, 3597
Yes 6.0% (4.6–7.7) 1.53 (1.07–2.19) 1560, 1666 3.6% (2.8–4.4) 0.97 (0.73–1.29) 2662, 2152
Current depression
(PHQ-2)c
<0.0001 <0.0001
No 3.5% (2.9–4.2) 1.00 4384, 5472 3.0% (2.6–3.6) 1.00 5885, 5149
Yes 12.4% (9.1–16.6) 4.17 (2.77–6.26) 449, 495 8.9% (6.9–11.5) 3.12 (2.25–4.33) 780, 602
CULTURAL/RELIGIOUS FACTORS
Religion important
and practiced
regularly
0.6125 0.1346
No 4.2% (3.5–4.9) 1.00 4481, 5453 3.8% (3.3–4.4) 1.00 6047, 5100
Yes 5.2% (3.1–8.6) 1.16 (0.65–2.07) 349, 506 2.4% (1.3–4.3) 0.62 (0.33–1.16) 609, 644
Sex without love is
OK
0.9122 0.1004
No 4.5% (3.4–5.8) 1.00 1586, 2097 3.2% (2.5–4.0) 1.00 3291, 2968
Yes 4.2% (3.4–5.1) 1.02 (0.72–1.45) 3233, 3852 4.1% (3.4–5.0) 1.29 (0.95–1.76) 3347, 2761
People are under
pressure to have
sex
0.1817 0.0158
No 3.7% (2.8–4.9) 1.00 1737, 2176 2.6% (1.9–3.6) 1.00 1761, 1485
Yes 4.6% (3.8–5.6) 1.28 (0.89–1.85) 3039, 3708 4.1% (3.5–4.8) 1.61 (1.09–2.37) 4817, 4185
(Continued )
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in the past year), as well as with depression (4.17; 2.77–6.26)
and three of the four ‘partner and sexual relationship’ variables.
Unlike women, there was no association with agreeing that
‘people are under pressure to have sex’ (1.28; 0.89–1.85). The
analysis of individual problems showed no instances of strong
effects in opposite directions, again suggesting that associations
are broadly consistent across problems (supplemental data
Table 1). However, lacking interest in sex appeared more
strongly associated than the other individual problems with
partner and relationship factors; we also found that difﬁculty
reaching climax was more closely associated than the other
individual problems with attitudes to sex (disagreeing that
“sex without love is ok” and that agreeing that “people are
under pressure to have sex”) and that associations with health
were less strong for reaching climax too quickly.
A second regression model to analyze associations with
one or more sexual function problem, whether meeting
morbidity criteria or not, showed similar results to Table 3
(data not shown).
Seeking Professional Help
Among men reporting one or more morbid sexual func-
tion problems (Figure 2), professional help was most
commonly sought, by just over 60% of men, for trouble
getting or keeping an erection. It was least commonly
sought (under 10%), by men reporting difﬁculty with early
climax. Across all morbid problems, just over a third of men
had sought professional help about their sex life in the last
year. Among women, help seeking in the last year was most
common among those reporting a problem with interest and
arousal (51.8% of women meeting all three morbidity cri-
teria). Again, across all problems, just over a third of
women had sought professional help in the past year.
Discussion
DSM-5 represented a signiﬁcant shift in the classiﬁcation
of sexual dysfunction, most notably in relation to the classi-
ﬁcation of female disorders, but also with regard to the level
of morbidity required for diagnosis. Changes in DSM criteria
clearly have a bearing on the measurement of disorders in
epidemiological studies and these Natsal-3 data, to our
knowledge, are the ﬁrst to indicate the likely nature of these
changes. In the sexually active British population, we found
that among sexually active men, the prevalence of reporting
one or more of four speciﬁc sexual problems was 38.2%, but
Table 4. (Continued)
Men Women
% 95% C.I. aAOR 95% C.I. p-value Denominatorsa % 95% C.I. aAOR 95% C.I. p-value Denominatorsa
MEDICAL
FACTORS
Number of self-
reported chronic
conditionsd
<0.0001 <0.0001
0 3.0% (2.4–3.8) 1.00 3456, 3996 2.5% (2.0–3.1) 1.00 4357, 3536
1 4.6% (3.4–6.1) 1.39 (0.90–2.16) 920, 1302 4.5% (3.5–5.8) 2.07 (1.47–2.92) 1544, 1405
2+ 11.0% (8.0–14.8) 3.35 (2.03–5.51) 464, 678 7.1% (5.2–9.6) 3.90 (2.60–5.85) 767, 814
Health condition
affecting sexual
activity or
enjoyment
<0.0001 <0.0001
No 2.3% (1.8–2.9) 1.00 4170, 5061 1.8% (1.5–2.2) 1.00 5515, 4712
Yes 15.0% (12.2–18.4) 6.89 (4.81–9.86) 656, 898 11.9% (9.8–14.4) 7.44 (5.48–10.09) 1147, 1038
Medication that
affected sexual
activity last year
<0.0001 <0.0001
No 3.3% (2.8–4.1) 1.00 4492, 5513 2.9% (2.5–3.5) 1.00 6170, 5318
Yes 15.2% (11.4–19.9) 4.46 (2.96–6.72) 332, 444 12.4% (9.4–16.2) 4.67 (3.27–6.69) 492, 431
Uncomfortably dry
vagina
- <0.0001
No - - - - - 2.3% (1.9–2.7) 1.00 5920, 5010
Yes - - - - - 13.0% (10.4–16.1) 7.19 (5.23–9.87) 749, 746
aAOR = age-Adjusted Odds Ratio; PHQ-2 = Patient Health Questionnaire-2
aUnweighted, weighted denominators
bDeﬁned as anyone having sex with you against your will after the age of 13 years
cTwo screening questions (scored 0–3 per question; deﬁned here by a total score of 3 or more) assessed depressive symptoms (PHQ-2; Arroll, 2003; Arroll
et al., 2010)
dIncludes arthritis, heart attack, coronary heart disease, angina, other forms of heart disease, hypertension, stroke, diabetes, broken hip or pelvis bone or hip
replacement ever, backache lasting longer than 3 months, any other muscle or bone disease lasting longer than 3 months, depression, cancer, and any thyroid
condition treated in the past year
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4.2% after applying the three DSM-5 morbidity criteria.
Among sexually active women, the prevalence of reporting
one or more of three speciﬁc sexual problems was 22.8%, but
3.6% after applying the three morbidity criteria. Of all men
and women reporting one or more of the seven sexual func-
tion problems lasting three months or more in the last year,
11.1% of men and 16% of women reported at least one
problem that met all three DSM-5 morbidity criteria.
The strength of our study is that it is based on a large sample
with a wide age range and is representative of the British adult
population (Erens et al., 2013;Mercer et al., 2013).We achieved
a response rate in line with other major social surveys in Britain
(Park, Clery, Curtice, Phillips, & Utting, 2012) and higher than
many surveys of sexual dysfunction (Christensen et al., 2011;
Laumann et al., 2006). A limitation is that we report the pre-
valence of sexual function problems approximating the DSM-5
criteria for morbidity, rather than the prevalence of clinical
sexual disorders as classiﬁed by DSM-5. It is not feasible for
cross-sectional surveys to provide sufﬁcient clinical information
for a deﬁnite diagnosis (Graham & Bancroft, 2005). For
instance, the DSM-5 stipulates that if the sexual problem is
attributable to a medical condition, then a diagnosis of sexual
dysfunction is not given (American Psychiatric Association,
2013); it is not possible to ascertain such causality in a cross-
sectional survey. Furthermore, there were notable differences in
the deﬁnition of individual sexual problems in our study com-
pared with the DSM-5. For instance, the new DSM-5 Female
Sexual Interest//Arousal Disorder uses a polythetic approach,
requiring three of six possible symptoms to be present. In
Natsal-3 we approximated this classiﬁcation by including
women who reported both lack of interest and lack of excite-
ment/arousal. The extent to which our combined category repre-
sents an adequate proxy for the new DSM-5 diagnostic criteria
is unknown as there are not yet prevalence studies using the new
polythetic approach; it is likely that including only women who
report lack of interest AND lack of excitement/arousal gives rise
to a lower prevalence estimate than requiring the presence of 3
out of 6 symptoms of FSIAD (either arousal or desire symp-
toms). Other Natsal-3 deﬁnitions were less strict than in DSM-5;
for premature ejaculation we included all men who reported
reaching a climax more quickly than they would like, whereas
the DSM-5 diagnosis requires that men persistently experience
ejaculation within 1 minute of vaginal penetration and before
the individual wishes it. For these reasons we focus in this paper
on the impact of DSM-5 morbidity criteria on prevalence of
sexual function problems, rather than on the prevalence esti-
mates themselves. Finally, the small number of participants
meeting DSM-5 morbidity criteria limited our ability to explore
associations with individual problems with sufﬁcient accuracy.
As expected, our prevalence estimates using the DSM-5
morbidity criteria were lower than those of population studies
adopting less stringent severity criteria (Christensen et al., 2011;
Laumann, Glasser, Neves, & Moreira, 2009; Quinta Gomes &
Nobre, 2014). We also found lower levels of overlap between
different sexual problems than in previous studies (Quinta
Gomes & Nobre, 2014; Fugl-Meyer & Fugl-Meyer, 2002).
Overlap between diagnostic categories has previously been a
source of criticism of the DSM classiﬁcation because it leads to
increased complexity and reduced clinical utility (First, 2005). It
is difﬁcult to ascertain whether overlap is an artifact of the
classiﬁcation system or true co-morbidity (Maj, 2005), but in
terms of clinical utility, reduced overlap appears welcome.
An admirable feature of the DSM-5 classiﬁcation of
sexual dysfunction is the recognition of biological, psycho-
logical, and social factors (termed “associated features” in
DSM-5) in understanding etiology and informing treatment
decisions. Of the factors tested, our data provided strong
support for their inclusion in DSM-5 since, with few excep-
tions, they were signiﬁcantly associated with reporting mor-
bid sexual function problems. Moreover, since the
associations held for reports of all problems, regardless of
morbidity, these factors appear to be relevant, whether or
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Figure 2. Proportion of men and women with sexual function problems meeting DSM-5 morbidity criteria who sought professional help in the last year.
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not problems meet morbidity criteria. Our ﬁndings support
previous research demonstrating a strong contributing role
of both depression and anxiety (McCabe et al., 2010), and
for aspects of the sexual relationship such as compatibility
(Witting et al., 2008). We also identiﬁed some interesting
gender differences: unemployment was associated with
male but not female dysfunction, and experience of non-
volitional sex was more strongly associated among women
(although the lack of an association in men may be in part
be due to small numbers). We found no association with
religiosity but this is possibly because the complexity of the
construct and diversity of inﬂuence across individuals
makes it difﬁcult to capture in a brief survey item.
Implications for Research and Practice
If we are to address the inconsistent measurement of
severity in epidemiological studies, then adoption of stan-
dardized criteria, such as those in DSM-5, seems an appro-
priate way forward. Studies adopting these criteria should
expect that of those reporting a sexual function problem,
around 1 in 10 men and 1 in 6 women would meet all three
morbidity criteria. Although logically, the morbidity criteria
exclude those reporting milder symptoms and include those
reporting more severe symptoms, a clinical study of speci-
ﬁcity/sensitivity is required to judge the extent to which the
criteria result in false negatives and false positives.
Previous surveys have emphasized the pervasiveness of
sexual dysfunction, for example, the oft-cited, though highly
criticized, estimates of 43% for women and 31% for men
(Laumann et al., 1999). The close involvement of the pharma-
ceutical industry in the measurement and classiﬁcation of sexual
dysfunction has attracted signiﬁcant criticism (Marshall, 2009;
Moynihan, 2010; Tiefer, 2006). The industry has been accused
of ‘disease mongering,’ including tactics such as encouraging
mild symptoms to be viewed as severe and using prevalence
estimates to suggest large numbers of people affected, with the
purpose of creating demand for pharmacological intervention
(Moynihan, Heath, & Henry, 2002; Payer, 1992; Tiefer, 2006).
Prevalence studies have also been conducted against a back-
ground of increased labeling and medicalization of behavior in
general, and concomitant rise in medication to treat behavioural
disorders (Spence, 2012). Applying more stringent morbidity
criteria certainly gives rise to lower estimates and the consider-
able size of the reduction suggests that previous prevalence
ﬁgures may have over-estimated the scale of the problem.
However, our data still suggest signiﬁcant numbers of
affected individuals: 8.9 million adults in the US and 1.8
million adults in the UK.2 These estimates are conservative
since they are based on the sexually active population and
omit those who may not be having sex because of sexual
problems. In the same study (Mitchell et al., 2013) we found
that among those who were ever sexually experienced
(n = 1,034 men and n = 1,685 women), 21% of men and
17% of women reported avoiding sex because of a sexual
difﬁculty, either their own or a partner’s. Of this group, it
could be assumed that at least the same proportion as in this
study (11% of men and 16% of women reporting any pro-
blem, among sexually active participants) met all three
morbidity criteria for the problem they were avoiding but
were not included in the overall prevalence estimates. This
equates to 24 men and 46 women in our sample. Our data on
help-seeking also suggest a high level of unmet need; almost
two-thirds of men and women with morbid symptoms did
not seek professional help for their sex life in the past year.
Conclusion
The new DSM-5 morbidity criteria impose a focus on
individuals who are experiencing persistent, frequent and
distressing symptoms. Implementing these criteria in a popu-
lation survey leads to much lower prevalence estimates and
reduces overlap between problems. It is possible that preva-
lence estimates using insufﬁciently stringent morbidity cri-
teria actually weaken arguments for resources by producing
estimates that are not particularly credible (Balon, 2008) and
by inducing inertia because the disease burden seems so
large. The new DSM-5 morbidity criteria are welcome not
only because they concentrate on those with clinically sig-
niﬁcant symptoms, but also because they suggest that it may
be possible to address the disease burden caused by sexual
problems, given sufﬁcient commitment and resources.
Acknowledgments
Natsal-3 is a collaboration between University College
London (London, UK), the London School of Hygiene and
Tropical Medicine (London, UK), NatCen Social Research,
Public Health England (formerly the Health Protection
Agency), and the University of Manchester (Manchester,
UK). We thank the study participants, the team of interviewers
from NatCen Social Research, Heather Wardle, Vicki
Hawkins, Cathy Coshall, and operations and computing staff
from NatCen Social Research. KRM and CHM had full access
to all of the data in the study and take responsibility for the
integrity of the data and the accuracy of the data analysis. Anne
M. Johnson is a Governor of the Wellcome Trust. All other
authors declare that they have no conﬂicts of interest.
Funding
The study was supported by grants from the Medical Research
Council (G0701757) and the Wellcome Trust (084840), with
contributions from the Economic and Social Research Council
and Department of Health. NF is funded by a NIHR Academic
Clinical Lectureship. KGJ was funded by a NIHR Research
Methods Fellowship. The funders had no role in the design and
2 Estimate based on 2014 census estimates for adults aged 16-74. Data
for UK from Ofﬁce for National Statistics (2015), and for US from US
Census Bureau, Population Division (2015).
MORBIDITY CRITERIA AND SEXUAL DYSFUNCTION
965
conduct of the study; collection, management, analysis, and
interpretation of the data; and preparation, review, or approval
of the manuscript; and decision to submit the manuscript for
publication.
Supplemental Material
Supplemental data for this article can be found online at
http://www.tandfonline.com/hjsr.
References
American Psychiatric Association (2000). Diagnostic and statistical man-
ual of mental disorders (4th ed., text rev.). Arlington, VA: Author.
American Psychiatric Association. (2013). Diagnostic and statistical man-
ual of mental disorders (5th ed.). Arlington, VA: Author.
Arroll, B. (2003). Screening for depression in primary care with two
verbally asked questions: Cross sectional study. British Medical
Journal, 327, 1144–1146. doi:10.1136/bmj.327.7424.1144
Arroll, B., Goodyear-Smith, F., Crengle, S., Gunn, J., Kerse, N., Fishman,
T., & Hatcher, S. (2010). Validation of PHQ-2 and PHQ-9 to screen
for major depression in the primary care population. Annals of Family
Medicine, 8, 348–353.
Balon, R. (2008). The DSM criteria of sexual dysfunction: Need for a
change. Journal of Sex & Marital Therapy, 34, 186–197.
Balon, R., & Clayton, A. (2014). Female sexual interest/arousal disorder: A
diagnosis out of thin air. Archives of Sexual Behavior, 43, 1227–1229.
doi:10.1007/s10508-013-0247-1
Balon, R., Segraves, R. T., & Clayton, A. H. (2007). Issues for DSM-V:
Sexual dysfunction, disorder or variation along a normal distribution.
Toward rethinking DSM criteria of sexual dysfunction. American
Journal of Psychiatry, 164, 198–200.
Binik, Y. M., Brotto, L., Graham, C. A., & Segraves, R. T. (2010). Response
of the DSM-V sexual dysfunctions subworkgroup to commentaries
published in JSM. Journal of Sexual Medicine, 7, 2382–2387.
Carvalheira, A. A., Brotto, L. A., & Leal, I. (2010). Women’s motivations
for sex: Exploring the Diagnostic and Statistical Manual, fourth edi-
tion, text revision criteria for hypoactive sexual desire and female
sexual arousal disorders. Journal of Sexual Medicine, 7, 1454–1463.
Christensen, B. S., Grønbæk, M., Osler, M., Pedersen, B. V., Graugaard, C.,
& Frisch, M. (2011). Sexual dysfunctions and difﬁculties in Denmark:
Prevalence and associated sociodemographic factors. Archives of
Sexual Behavior, 40, 121–132.
Clayton, A. H., DeRogatis, L. R., Rosen, R. C., & Pyke, R. (2012).
Intended or unintended consequences? The likely implications of
raising the bar for sexual dysfunction diagnosis in the proposed
DSM V Revisions: 2. For Women with loss of subjective sexual
arousal. Journal of Sexual Medicine, 9, 2040–2046.
Derogatis, L. R., & Burnett, A. L. (2008). The epidemiology of sexual
dysfunctions. Journal of Sexual Medicine, 5(2), 289–300.
Erens, B., Phelps, A., Clifton, S., Mercer, C. H., Tanton, C., Hussey, D., …
Johnson, A. M. (2014). Methodology of the third British National
Survey of Sexual Attitudes and Lifestyles (Natsal-3). Sexually
Transmitted Infecions, 90, 84–89.
First, M. B. (2005). Mutually exclusive versus co-occuring diagnostic
categories: The challenge of diagnostic co-morbidity.
Psychopathology, 338, 206–210.
Fugl-Meyer, K. S., & Fugl-Meyer, A. R. (2002). Sexual disabilities are not
singularities. International Journal of Impotence Research, 14, 487–493.
Graham, C. A. (2015). Reconceptualisng women’s sexual desire and arousal in
DSM-5.Psychology and Sexuality. doi:10.1080/19419899.2015.1024469
Graham, C. A., & Bancroft, J. (2005). Assessing the prevalence of female
sexual dysfunction with surveys: What is feasible? In I. Goldstein, C.
Meston, S. Davis, & A. Traish (Eds.), Women’s sexual function and
dysfunction: Study diagnosis and treatment (pp. 52–60). London,
England: Taylor & Francis.
Graham, C. A., Brotto, L. A., & Zucker, K. J. (2014). Response to Balon
and Clayton (2014): Female sexual interest/arousal disorder is a diag-
nosis more on ﬁrm ground than thin air. Archives of Sexual Behavior,
43, 1231–1234. doi:10.1007/s10508-013-0248-0
Gray, M., & Nicholson, S. (2009). National Survey of Sexual Attitudes and
Lifestyles 2010: Findings and recommendations from cognitive ques-
tion testing. Retrieved from: http://www.natsal.ac.uk/media/822297/
natsal%202010_cognitive%20pilot%20report%20-%20ﬁnal.pdf.
[Accessed October 30, 2013]
Hendrickx, L., Gijs, L., & Enzlin, P. (2013). Distress, sexual dysfunctions
and DSM: Dialogue at cross purposes? Journal of Sexual Medicine,
10, 630–641.
Laumann, E. O., Glasser, D. B., Neves, R. C., & Moreira, E. D., Jr. (2009).
A population-based survey of sexual activity, sexual problems and
associated help-seeking behavior patterns in mature adults in the
United States of America. International Journal of Impotence
Research, 21, 171–178.
Laumann, E. O., Paik, A., Glasser, D. B., Kang, J. H., Wang, T., Levinson,
B., … Gingell, C. (2006). A cross-national study of subjective sexual
well-being among older women and men: Findings from the global
study of sexual attitudes and behaviors. Archives of Sexual Behavior,
35, 145–161. doi:10.1007/s10508-005-9005-3
Laumann, E. O., Paik, A., & Rosen, R. C. (1999). Sexual dysfunction in the
United States. Journal of the American Medical Association, 281,
537–544. doi:10.1001/jama.281.6.537
Maj, M. (2005). ‘Psychiatric comorbidity’: An artefact of current diagnostic
systems? The British Journal of Psychiatry, 186, 182–184. doi:10.1192/
bjp.186.3.182
Marshall, B. (2009). Sexual medicine, sexual bodies and the ‘pharmaceu-
tical imagination’. Science as Culture, 18(2), 133–149. doi:10.1080/
09505430902885466
McCabe, M., Althof, S. E., Assalian, P., Chevret-Measson, M., Leiblum, S.
R., Simonelli, C., & Wylie, K. (2010). Psychological and interpersonal
dimensions of sexual function and dysfunction. Journal of Sexual
Medicine, 7(1 Pt 2), 327–336.
Mercer, C. H., Tanton, C., Prah, P., Erens, B., Sonnenberg, P., Clifton, S.…
Wellings, K., & Johnson, A. M. (2013). Changes in sexual attitudes
and lifestyles in Britain through the life course and over time: Findings
from the national surveys of sexual attitudes and lifestyles (Natsal).
The Lancet, 382, 1781–1794.
Mitchell, K. R., & Graham, C. A. (2008). Two challenges for the classiﬁca-
tion of sexual dysfunction. Journal of Sexual Medicine, 5, 1552–1558.
doi:10.1111/jsm.2008.5.issue-7
Mitchell, K. R., Mercer, C. H., Ploubidis, G. B., Jones, K. G., Datta, J.,
Field, J., … Johnson, A. M., & Wellings, K. (2013). Sexual function
in Britain: Findings from the third national survey of sexual attitudes
and lifestyles (Natsal-3). The Lancet, 382, 1817–1829. doi:10.1016/
S0140-6736(13)62366-1
Moynihan, R. (2010). Merging of marketing and medical science: Female
sexual dysfunction. British Medical Journal, 341, c5050–c5050.
doi:10.1136/bmj.c5050
Moynihan, R., Heath, I., & Henry, D. (2002). Selling sickness: The phar-
maceutical industry and disease mongering. British Medical Journal,
324, 886–891. doi:10.1136/bmj.324.7342.886
Ofﬁce for National Statistics. (2015). Population estimates for UK,
England and Wales, Scotland and Northern Ireland, mid-2014.
Retrieved from http://www.ons.gov.uk/ons/rel/pop-estimate/popula
tion-estimates-for-uk–england-and-wales–scotland-and-northern-ire
land/mid-2014/rft—mid-2014-uk-population-estimates.zip
Park, A., Clery, E., Curtice, J., Phillips, M., & Utting, D. (2012). British
social attitudes: The 28th report. London, England: NatCen.
Payer, L. (1992). Disease-Mongers: How doctors, drug companies and
insurers are making you feel sick. USA: John Wiley & Sons.
Payne, R. A., & Abel, G. A. (2012). UK indices of multiple deprivation – a
way to make comparisons across constituent countries easier. Health
Statistics Quarterly, 53, 22–37.
MITCHELL ET AL.
966
Quinta Gomes, A. L., & Nobre, P. J. (2014). Prevalence of sexual problems
in Portugal: Results of a population-based study using a stratiﬁed
sample of men aged 18 to 70 years. Journal of Sex Research, 51,
13–21.
Sand, M., & Fisher, W. A. (2007). Women’s endorsement of models of
female sexual response: The nurses’ sexuality study. Journal of Sexual
Medicine, 4(3), 708–719.
Spence, D. (2012). The psychiatric oligarchs who medicalise normality.
British Medical Journal, 344, e3135.
Sungur, M. Z., & Gündüz, A. (2014). A comparison of DSM-IV-TR and
DSM-5 deﬁnitions for sexual dysfunctions: Critiques and chal-
lenges. Journal of Sexual Medicine, 11, 364–373. doi:10.1111/
jsm.12379
Tiefer, L. (2006). Female sexual dysfunction: A case study of disease
mongering and activist resistance. PLoS Medicine, 3(4), e178.
doi:10.1371/journal.pmed.0030178
Tiefer, L. (2012). Medicalizations and demedicalizations of sexuality thera-
pies. Journal of Sex Research, 49, 311–318. doi:10.1080/00224499.
2012.678948
US Census Bureau, Population Division. (2015). Annual estimates of the
resident population by sex, single year of age, race alone or in
combination, and Hispanic origin for the United States: April 1,
2010 to July 1, 2014. Retrieved from http://factﬁnder.census.gov/
faces/tableservices/jsf/pages/productview.xhtml?pid=PEP_2014_
PEPALL5N&prodType=table
Wakeﬁeld, J. C. (1992). The concept of mental disorder: On the boundary
between biological facts and social values. American Psychologist, 47,
373–388. doi:10.1037/0003-066X.47.3.373
Witting, K., Santtila, P., Varjonen, M., Jern, P., Johansson, A., Von Der
Pahlen, B., & Sandnabba, K. (2008). Female sexual dysfunction,
sexual distress and compatibility with partner. Journal of Sexual
Medicine, 5, 2587–2599. doi:10.1111/jsm.2008.5.issue-11
MORBIDITY CRITERIA AND SEXUAL DYSFUNCTION
967
